WCN26-9318 HEPATITIS B VACCINE IMMUNOGENICITY IN A KENYAN HEMODIALYSIS UNIT: A RETROSPECTIVE ANALYSIS OF SEROPROTECTION GAPS

Read full text Summarise with VIRAT
Authors: Ahmed Twahir, Seth O McLigeyo, Wambugu Maranga, Abdullahi Hadi, Kevin Nguring’a
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Patients with end-stage kidney disease (ESKD) on maintenance haemodialysis (HD) are at an increased risk of acquiring hepatitis B virus (HBV) infection. Active hepatitis B virus (HBV) immunization in these patients is therefore recommended. Hepatitis B immunological response rate in patients on maintenance HD is variable but generally lower than that of healthy individuals.

Fields of Study & Subjects

Hepatitis B Virus Studies Hepatitis C virus research Intramuscular injections and effects

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104959–104959
Publication date
25 March 2026
Language
EN